{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:57:59Z","timestamp":1790675879166,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00108-026-02172-8","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:28:01Z","timestamp":1787729281000},"page":"1086-1099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarkopenie\u00a0\u2013 Diagnose, klinische Konsequenzen und Therapie","Sarcopenia: diagnosis, clinical implications, and treatment"],"prefix":"10.1007","volume":"67","author":[{"given":"Stephan","family":"von Haehling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A. F.","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(00)90705-0","volume":"217","author":"M Critchley","year":"1931","unstructured":"Critchley\u00a0M (1931) The neurology of old age. Lecture II: Clinical manifestations in old age. Lancet 217:1119\u20131127","journal-title":"Lancet"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/ajcn\/50.5.1231","volume":"50","author":"IH Rosenberg","year":"1989","unstructured":"Rosenberg\u00a0IH (1989) Summary Comments. Am J Clin Nutr 50:1231\u20131233","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"2172_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","volume":"5","author":"JE Morley","year":"2014","unstructured":"Morley\u00a0JE, Anker\u00a0SD, von Haehling\u00a0S (2014) Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J\u00a0Cachexia Sarcopenia Muscle 5(4):253\u2013259. https:\/\/doi.org\/10.1007\/s13539-014-0161-y","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"2172_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jcsm.12147","volume":"7","author":"SD Anker","year":"2016","unstructured":"Anker\u00a0SD, Morley\u00a0JE, von Haehling\u00a0S (2016) Welcome to the ICD-10 code for sarcopenia. J\u00a0Cachexia Sarcopenia Muscle 7(5):512\u2013514. https:\/\/doi.org\/10.1002\/jcsm.12147","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"2172_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","volume":"14","author":"TK Malmstrom","year":"2013","unstructured":"Malmstrom\u00a0TK, Morley\u00a0JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J\u00a0Am Med Dir Assoc 14(8):531\u2013532. https:\/\/doi.org\/10.1016\/j.jamda.2013.05.018","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"2172_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae052","volume":"53","author":"B Kirk","year":"2024","unstructured":"Kirk\u00a0B, Cawthon\u00a0PM, Arai\u00a0H, \u00c1vila-Funes\u00a0JA, Barazzoni\u00a0R, Bhasin\u00a0S, Binder\u00a0EF, Bruyere\u00a0O, Cederholm\u00a0T, Chen\u00a0LK, Cooper\u00a0C, Duque\u00a0G, Fielding\u00a0RA, Guralnik\u00a0J, Kiel\u00a0DP, Landi\u00a0F, Reginster\u00a0JY, Sayer\u00a0AA, Visser\u00a0M, von Haehling\u00a0S, Woo\u00a0J, Cruz-Jentoft\u00a0AJ, Global Leadership Initiative in Sarcopenia (GLIS) group (2024) The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing 53(3):afae052. https:\/\/doi.org\/10.1093\/ageing\/afae052","journal-title":"Age Ageing"},{"issue":"Suppl 1","key":"2172_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/ggi.12723","volume":"16","author":"H Kim","year":"2016","unstructured":"Kim\u00a0H, Hirano\u00a0H, Edahiro\u00a0A, Ohara\u00a0Y, Watanabe\u00a0Y, Kojima\u00a0N et\u00a0al (2016) Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16(Suppl 1):110\u2013122","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"2172_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha\u00a0F, Balntzi\u00a0V, Gray\u00a0SR, Lara\u00a0J, Ho\u00a0FK, Pell\u00a0JP et\u00a0al (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J\u00a0Cachexia Sarcopenia Muscle 13(1):86\u201399","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2172_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105596","volume":"128","author":"SE Weng","year":"2025","unstructured":"Weng\u00a0SE, Huang\u00a0YW, Tseng\u00a0YC, Peng\u00a0HR, Lai\u00a0HY, Akishita\u00a0M et\u00a0al (2025) The Evolving Landscape of Sarcopenia in Asia: A Systematic review and meta-analysis following the 2019 Asian working group for sarcopenia (AWGS) diagnostic criteria. Archives of gerontology and geriatrics 128:105596","journal-title":"Archives of gerontology and geriatrics"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.exger.2014.11.014","volume":"61","author":"C Beaudart","year":"2015","unstructured":"Beaudart\u00a0C, Reginster\u00a0JY, Slomian\u00a0J, Buckinx\u00a0F, Dardenne\u00a0N, Quabron\u00a0A et\u00a0al (2015) Estimation of sarcopenia prevalence using various assessment tools. Exp Gerontol 61:31\u201337","journal-title":"Exp Gerontol"},{"issue":"2","key":"2172_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13539-010-0014-2","volume":"1","author":"S von Haehling","year":"2010","unstructured":"von Haehling\u00a0S, Morley\u00a0JE, Anker\u00a0SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J\u00a0Cachexia Sarcopenia Muscle 1(2):129\u2013133","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"2172_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00223-016-0220-9","volume":"100","author":"O Ethgen","year":"2017","unstructured":"Ethgen\u00a0O, Beaudart\u00a0C, Buckinx\u00a0F, Bruy\u00e8re\u00a0O, Reginster\u00a0JY (2017) The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcified tissue international 100(3):229\u2013234","journal-title":"Calcified tissue international"},{"issue":"3","key":"2172_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00223-016-0220-9","volume":"100","author":"O Ethgen","year":"2017","unstructured":"Ethgen\u00a0O, Beaudart\u00a0C, Buckinx\u00a0F, Bruy\u00e8re\u00a0O, Reginster\u00a0JY (2017) The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcif Tissue Int 100(3):229\u2013234. https:\/\/doi.org\/10.1007\/s00223-016-0220-9","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2172_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-04694-y","volume":"24","author":"C Steinmetz","year":"2024","unstructured":"Steinmetz\u00a0C, Krause\u00a0L, Sulejmanovic\u00a0S, Kaumk\u00f6tter\u00a0S, Mengden\u00a0T, Grefe\u00a0C et\u00a0al (2024) The prevalence and impact of sarcopenia in older cardiac patients undergoing inpatient cardiac rehabilitation - results from a prospective, observational cohort pre-study. BMC geriatrics 24(1):94","journal-title":"BMC geriatrics"},{"issue":"3","key":"2172_CR15","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/jcsm.12993","volume":"13","author":"HJ Choe","year":"2022","unstructured":"Choe\u00a0HJ, Cho\u00a0BL, Park\u00a0YS, Roh\u00a0E, Kim\u00a0HJ, Lee\u00a0SG et\u00a0al (2022) Gender differences in risk factors for the 2 year development of sarcopenia in community-dwelling older adults. J\u00a0Cachexia Sarcopenia Muscle 13(3):1908\u20131918","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2172_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102148","volume":"93","author":"R Lian","year":"2024","unstructured":"Lian\u00a0R, Liu\u00a0Q, Jiang\u00a0G, Zhang\u00a0X, Tang\u00a0H, Lu\u00a0J, Yang\u00a0M (2024) Blood biomarkers for sarcopenia: A systematic review and meta-analysis of diagnostic test accuracy studies. Ageing Res Rev 93:102148. https:\/\/doi.org\/10.1016\/j.arr.2023.102148","journal-title":"Ageing Res Rev"},{"key":"2172_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.112005","volume":"222","author":"F Veronesi","year":"2024","unstructured":"Veronesi\u00a0F, Salamanna\u00a0F, Borsari\u00a0V, Ruffilli\u00a0A, Faldini\u00a0C, Giavaresi\u00a0G (2024) Unlocking diagnosis of sarcopenia: The role of circulating biomarkers - A clinical systematic review. Ageing Res Rev 222:112005. https:\/\/doi.org\/10.1016\/j.mad.2024.112005","journal-title":"Mech Ageing Dev"},{"issue":"12","key":"2172_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/ejhf.400","volume":"17","author":"L Steinbeck","year":"2015","unstructured":"Steinbeck\u00a0L, Ebner\u00a0N, Valentova\u00a0M, Bekfani\u00a0T, Elsner\u00a0S, Dahinden\u00a0P, Hettwer\u00a0S, Scherbakov\u00a0N, Schefold\u00a0JC, Sandek\u00a0A, Springer\u00a0J, Doehner\u00a0W, Anker\u00a0SD, von Haehling\u00a0S (2015) Detection of muscle wasting in patients with chronic heart failure using C\u2011terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail 17(12):1283\u20131293. https:\/\/doi.org\/10.1002\/ejhf.400","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2172_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jcsm.12068","volume":"7","author":"N Scherbakov","year":"2016","unstructured":"Scherbakov\u00a0N, Knops\u00a0M, Ebner\u00a0N, Valentova\u00a0M, Sandek\u00a0A, Grittner\u00a0U, Dahinden\u00a0P, Hettwer\u00a0S, Schefold\u00a0JC, von Haehling\u00a0S, Anker\u00a0SD, Joebges\u00a0M, Doehner\u00a0W (2016) Evaluation of C\u2011terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation. J\u00a0Cachexia Sarcopenia Muscle 7(1):60\u201367. https:\/\/doi.org\/10.1002\/jcsm.12068","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"2172_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jcsm.13189","volume":"14","author":"E Monti","year":"2023","unstructured":"Monti\u00a0E, Sarto\u00a0F, Sartori\u00a0R, Zanchettin\u00a0G, L\u00f6fler\u00a0S, Kern\u00a0H, Narici\u00a0MV, Zampieri\u00a0S (2023) C\u2011terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review. J\u00a0Cachexia Sarcopenia Muscle 14(2):730\u2013744. https:\/\/doi.org\/10.1002\/jcsm.13189","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"2172_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70284","volume":"24","author":"M Vatic","year":"2025","unstructured":"Vatic\u00a0M, Derda\u00a0AA, Garfias-Veitl\u00a0T, Sato\u00a0R, Lon\u010dar\u00a0G, Fibbi\u00a0G, Doehner\u00a0W, B\u00e4r\u00a0C, Landi\u00a0F, Calvani\u00a0R, Tosato\u00a0M, Bernabei\u00a0R, Marzetti\u00a0E, Kob\u00a0R, Sieber\u00a0C, Anker\u00a0SD, Thum\u00a0T, von Haehling\u00a0S (2025) Different Pattern in Circulating MicroRNA-22-3p Levels Between Patients With Primary Versus Secondary Sarcopenia. Aging Cell 24(12):e70284. https:\/\/doi.org\/10.1111\/acel.70284","journal-title":"Aging Cell"},{"issue":"1","key":"2172_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcsm.12390","volume":"10","author":"WJ Evans","year":"2019","unstructured":"Evans\u00a0WJ, Hellerstein\u00a0M, Orwoll\u00a0E, Cummings\u00a0S, Cawthon\u00a0PM (2019) D3 -Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass. J\u00a0Cachexia Sarcopenia Muscle 10(1):14\u201321. https:\/\/doi.org\/10.1002\/jcsm.12390","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"2172_CR23","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/jcsm.13083","volume":"13","author":"C McCarthy","year":"2022","unstructured":"McCarthy\u00a0C, Schoeller\u00a0D, Brown\u00a0JC, Gonzalez\u00a0MC, Varanoske\u00a0AN, Cataldi\u00a0D, Shepherd\u00a0J, Heymsfield\u00a0SB (2022) D3 -creatine dilution for skeletal muscle mass measurement: historical development and current status. J\u00a0Cachexia Sarcopenia Muscle 13(6):2595\u20132607. https:\/\/doi.org\/10.1002\/jcsm.13083","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2172_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/gerona\/glaa111","volume":"76","author":"PM Cawthon","year":"2021","unstructured":"Cawthon\u00a0PM, Blackwell\u00a0T, Cummings\u00a0SR, Orwoll\u00a0ES, Duchowny\u00a0KA, Kado\u00a0DM, Stone\u00a0KL, Ensrud\u00a0KE, Cauley\u00a0JA, Evans\u00a0WJ (2021) Muscle Mass Assessed by the D3-Creatine Dilution Method and Incident Self-reported Disability and Mortality in a Prospective Observational Study of Community-Dwelling Older Men. J\u00a0Gerontol A Biol Sci Med Sci 76(1):123\u2013130. https:\/\/doi.org\/10.1093\/gerona\/glaa111","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"2172_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad280","volume":"79","author":"AP Pagano","year":"2024","unstructured":"Pagano\u00a0AP, Montenegro\u00a0J, Oliveira\u00a0CLP, Desai\u00a0N, Gonzalez\u00a0MC, Cawthon\u00a0PM, Evans\u00a0WJ, Prado\u00a0CM (2024) Estimating Muscle Mass Using D3-Creatine Dilution: A\u00a0Narrative Review of Clinical Implications and Comparison With Other Methods. J\u00a0Gerontol A Biol Sci Med Sci 79(4):glad280. https:\/\/doi.org\/10.1093\/gerona\/glad280","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"2172_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent\u00a0E, Morley\u00a0JE, Cruz-Jentoft\u00a0AJ, Arai\u00a0H, Kritchevsky\u00a0SB, Guralnik\u00a0J, Bauer\u00a0JM, Pahor\u00a0M, Clark\u00a0BC, Cesari\u00a0M, Ruiz\u00a0J, Sieber\u00a0CC, Aubertin-Leheudre\u00a0M, Waters\u00a0DL, Visvanathan\u00a0R, Landi\u00a0F, Villareal\u00a0DT, Fielding\u00a0R, Won\u00a0CW, Theou\u00a0O, Martin\u00a0FC, Dong\u00a0B, Woo\u00a0J, Flicker\u00a0L, Ferrucci\u00a0L, Merchant\u00a0RA, Cao\u00a0L, Cederholm\u00a0T, Ribeiro\u00a0SML, Rodr\u00edguez-Ma\u00f1as\u00a0L, Anker\u00a0SD, Lundy\u00a0J, Guti\u00e9rrez Robledo\u00a0LM, Bautmans\u00a0I, Aprahamian\u00a0I, Schols\u00a0JMGA, Izquierdo\u00a0M, Vellas\u00a0B (2018) International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J\u00a0Nutr Health Aging 22(10):1148\u20131161. https:\/\/doi.org\/10.1007\/s12603-018-1139-9","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"2172_CR27","doi-asserted-by":"publisher","first-page":"553.e1","DOI":"10.1016\/j.jamda.2017.03.019","volume":"18","author":"Y Yoshimura","year":"2017","unstructured":"Yoshimura\u00a0Y, Wakabayashi\u00a0H, Yamada\u00a0M, Kim\u00a0H, Harada\u00a0A, Arai\u00a0H (2017) Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J\u00a0Am Med Dir Assoc 18(6):553.e1\u2013553.e16. https:\/\/doi.org\/10.1016\/j.jamda.2017.03.019","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"2172_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jamda.2022.01.057","volume":"23","author":"AM Negm","year":"2022","unstructured":"Negm\u00a0AM, Lee\u00a0J, Hamidian\u00a0R, Jones\u00a0CA, Khadaroo\u00a0RG (2022) Management of Sarcopenia: A Network Meta-Analysis of Randomized Controlled Trials. J\u00a0Am Med Dir Assoc 23(5):707\u2013714. https:\/\/doi.org\/10.1016\/j.jamda.2022.01.057","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"2172_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s12603-021-1665-8","volume":"25","author":"M Izquierdo","year":"2021","unstructured":"Izquierdo\u00a0M, Merchant\u00a0RA, Morley\u00a0JE, Anker\u00a0SD, Aprahamian\u00a0I, Arai\u00a0H, Aubertin-Leheudre\u00a0M, Bernabei\u00a0R, Cadore\u00a0EL, Cesari\u00a0M, Chen\u00a0LK, de Souto Barreto\u00a0P, Duque\u00a0G, Ferrucci\u00a0L, Fielding\u00a0RA, Garc\u00eda-Hermoso\u00a0A, Guti\u00e9rrez-Robledo\u00a0LM, Harridge\u00a0SDR, Kirk\u00a0B, Kritchevsky\u00a0S, Landi\u00a0F, Lazarus\u00a0N, Martin\u00a0FC, Marzetti\u00a0E, Pahor\u00a0M, Ram\u00edrez-V\u00e9lez\u00a0R, Rodriguez-Ma\u00f1as\u00a0L, Rolland\u00a0Y, Ruiz\u00a0JG, Theou\u00a0O, Villareal\u00a0DT, Waters\u00a0DL, Won Won\u00a0C, Woo\u00a0J, Vellas\u00a0B, Fiatarone Singh\u00a0M (2021) International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. J\u00a0Nutr Health Aging 25(7):824\u2013853. https:\/\/doi.org\/10.1007\/s12603-021-1665-8","journal-title":"J Nutr Health Aging"},{"issue":"25","key":"2172_CR30","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1056\/NEJM199406233302501","volume":"330","author":"MA Fiatarone","year":"1994","unstructured":"Fiatarone\u00a0MA, O\u2019Neill\u00a0EF, Ryan\u00a0ND, Clements\u00a0KM, Solares\u00a0GR, Nelson\u00a0ME, Roberts\u00a0SB, Kehayias\u00a0JJ, Lipsitz\u00a0LA, Evans\u00a0WJ (1994) Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330(25):1769\u20131775. https:\/\/doi.org\/10.1056\/NEJM199406233302501","journal-title":"N Engl J Med"},{"issue":"1","key":"2172_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012424.pub2","volume":"1","author":"C Sherrington","year":"2019","unstructured":"Sherrington\u00a0C, Fairhall\u00a0NJ, Wallbank\u00a0GK, Tiedemann\u00a0A, Michaleff\u00a0ZA, Howard\u00a0K, Clemson\u00a0L, Hopewell\u00a0S, Lamb\u00a0SE (2019) Exercise for preventing falls in older people living in the community. Cochrane Database Syst Rev 1(1):CD012424. https:\/\/doi.org\/10.1002\/14651858.CD012424.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2172_CR32","unstructured":"Deutsche Gesellschaft f\u00fcr Ern\u00e4hrung e.\u202fV. (DGE), \u00d6sterreichische Gesellschaft f\u00fcr Ern\u00e4hrung (\u00d6GE) (Hrsg.): Referenzwerte f\u00fcr die N\u00e4hrstoffzufuhr. 3.\u00a0Auflage, 2. Erg\u00e4nzungslieferung, Neuer Umschau Buchverlag, Neustadt an der Weinstra\u00dfe 2025\/2026."},{"issue":"8","key":"2172_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","volume":"14","author":"J Bauer","year":"2013","unstructured":"Bauer\u00a0J, Biolo\u00a0G, Cederholm\u00a0T, Cesari\u00a0M, Cruz-Jentoft\u00a0AJ, Morley\u00a0JE, Phillips\u00a0S, Sieber\u00a0C, Stehle\u00a0P, Teta\u00a0D, Visvanathan\u00a0R, Volpi\u00a0E, Boirie\u00a0Y (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a\u00a0position paper from the PROT-AGE Study Group. J\u00a0Am Med Dir Assoc 14(8):542\u2013559. https:\/\/doi.org\/10.1016\/j.jamda.2013.05.021","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"2172_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clnu.2018.05.024","volume":"38","author":"D Volkert","year":"2019","unstructured":"Volkert\u00a0D, Beck\u00a0AM, Cederholm\u00a0T, Cruz-Jentoft\u00a0A, Goisser\u00a0S, Hooper\u00a0L, Kiesswetter\u00a0E, Maggio\u00a0M, Raynaud-Simon\u00a0A, Sieber\u00a0CC, Sobotka\u00a0L, van Asselt\u00a0D, Wirth\u00a0R, Bischoff\u00a0SC (2019) ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 38(1):10\u201347. https:\/\/doi.org\/10.1016\/j.clnu.2018.05.024","journal-title":"Clin Nutr"},{"issue":"10","key":"2172_CR35","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent\u00a0E, Morley\u00a0JE, Cruz-Jentoft\u00a0AJ, Arai\u00a0H, Kritchevsky\u00a0SB, Guralnik\u00a0J, Bauer\u00a0JM, Pahor\u00a0M, Clark\u00a0BC, Cesari\u00a0M, Ruiz\u00a0J, Sieber\u00a0CC, Aubertin-Leheudre\u00a0M, Waters\u00a0DL, Visvanathan\u00a0R, Landi\u00a0F, Villareal\u00a0DT, Fielding\u00a0R, Won\u00a0CW, Theou\u00a0O, Martin\u00a0FC, Dong\u00a0B, Woo\u00a0J, Flicker\u00a0L, Ferrucci\u00a0L, Merchant\u00a0RA, Cao\u00a0L, Cederholm\u00a0T, Ribeiro\u00a0SML, Rodr\u00edguez-Ma\u00f1as\u00a0L, Anker\u00a0SD, Lundy\u00a0J, Guti\u00e9rrez Robledo\u00a0LM, Bautmans\u00a0I, Aprahamian\u00a0I, Schols\u00a0JMGA, Izquierdo\u00a0M, Vellas\u00a0B (2018) International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J\u00a0Nutr Health Aging 22(10):1148\u20131161. https:\/\/doi.org\/10.1007\/s12603-018-1139-9","journal-title":"J Nutr Health Aging"},{"key":"2172_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3692","volume":"339","author":"HA Bischoff-Ferrari","year":"2009","unstructured":"Bischoff-Ferrari\u00a0HA, Dawson-Hughes\u00a0B, Staehelin\u00a0HB, Orav\u00a0JE, Stuck\u00a0AE, Theiler\u00a0R, Wong\u00a0JB, Egli\u00a0A, Kiel\u00a0DP, Henschkowski\u00a0J (2009) Fall prevention with supplemental and active forms of vitamin\u00a0D: a\u00a0meta-analysis of randomised controlled trials. BMJ 339:b3692. https:\/\/doi.org\/10.1136\/bmj.b3692","journal-title":"BMJ"},{"issue":"10","key":"2172_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103589","volume":"13","author":"SH Cheng","year":"2021","unstructured":"Cheng\u00a0SH, Chen\u00a0KH, Chen\u00a0C, Chu\u00a0WC, Kang\u00a0YN (2021) The Optimal Strategy of Vitamin D for Sarcopenia: A Network Meta-Analysis of Randomized Controlled Trials. Nutrients 13(10):3589. https:\/\/doi.org\/10.3390\/nu13103589","journal-title":"Nutrients"},{"issue":"4","key":"2172_CR38","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3945\/ajcn.116.143594","volume":"106","author":"CD Liao","year":"2017","unstructured":"Liao\u00a0CD, Tsauo\u00a0JY, Wu\u00a0YT, Cheng\u00a0CP, Chen\u00a0HC, Huang\u00a0YC, Chen\u00a0HC, Liou\u00a0TH (2017) Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults: a systematic review and meta-analysis. Am J Clin Nutr 106(4):1078\u20131091. https:\/\/doi.org\/10.3945\/ajcn.116.143594","journal-title":"Am J Clin Nutr"},{"key":"2172_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland\u00a0Y, Dray\u00a0C, Vellas\u00a0B, Barreto\u00a0PS (2023) Current and investigational medications for the treatment of sarcopenia. Metabol Open 149:155597. https:\/\/doi.org\/10.1016\/j.metabol.2023.155597","journal-title":"Metabolism: clinical and experimental"},{"issue":"10","key":"2172_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/gerona\/63.10.1076","volume":"63","author":"P Kortebein","year":"2008","unstructured":"Kortebein\u00a0P, Symons\u00a0TB, Ferrando\u00a0A, Paddon-Jones\u00a0D, Ronsen\u00a0O, Protas\u00a0E, Conger\u00a0S, Lombeida\u00a0J, Wolfe\u00a0R, Evans\u00a0WJ (2008) Functional impact of 10\u00a0days of bed rest in healthy older adults. J\u00a0Gerontol A Biol Sci Med Sci 63(10):1076\u20131081. https:\/\/doi.org\/10.1093\/gerona\/63.10.1076","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2172_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/rco2.70027","volume":"9","author":"S Von Haehling","year":"2026","unstructured":"Von Haehling\u00a0S (2026) Enobosarm in Muscle Wasting. JCSM Communications 9:e70027. https:\/\/doi.org\/10.1002\/rco2.70027","journal-title":"JCSM Communications"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02172-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:09:45Z","timestamp":1790672985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02172-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"2 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0von Haehling\n                      : A.\u00a0Finanzielle Interessen: Forschungsunterst\u00fctzung an die Universit\u00e4tsmedizin G\u00f6ttingen von Deutsches Zentrum f\u00fcr Herz-Kreislauf-Forschung e.\u202fV. (DZHK), IMI, Pharmacosmos, AstraZeneca, Amgen, Boehringer Ingelheim und Novo Nordisk. \u2013\u00a0Honorare f\u00fcr Vortr\u00e4ge von AstraZeneca, Bayer, Besins Healthcare, Boehringer Ingelheim, BRAHMS, CSL Vifor, Edwards Lifesciences, MSD, Novartis, Novo Nordisk, Pfizer und Pharmacosmos.\u00a0\u2013 Beratungst\u00e4tigkeit f\u00fcr AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, CSL Vifor, Edwards Lifesciences, LumiraDX, MSD, Novartis, Novo Nordisk, Pfizer und Pharmacosmos. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter Oberarzt der Universit\u00e4tsmedizin G\u00f6ttingen | Mitglied des Vorstands des Heart and Brain Centers G\u00f6ttingen, Sprecher der Arbeitsgruppe Herzinsuffizienz der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung (DGK), Chairman der Studiengruppe Coronary Artery Disease der Heart Failure Association of the European Society of Cardiology (ESC-HFA).\n                      C.A.F.\u00a0von Arnim\n                      : A.\u00a0Finanzielle Interessen: Forschungsgelder vom Innovationsfonds (Fonds des Gemeinsamen Bundesausschusses [G-BA], F\u00f6rderkennzeichen VF1_2016-201; 01NVF21010; 01VSF21019). Deutsche Forschungsgemeinschaft (DFG; GRK 2824: RP9; 540861493).\u00a0\u2013 Reisekosten und Vortragshonorare von Lilly, Novo Nordisk, Roche, Novartis, der Medical Tribune Verlagsgesellschaft mbH, der Landesvereinigung f\u00fcr Gesundheit und Akademie f\u00fcr Sozialmedizin Niedersachsen e.\u202fV., der FomF GmbH | Forum f\u00fcr medizinische Fortbildung und der Dr. Willmar Schwabe GmbH & Co. KG. \u2013\u00a0Honorare f\u00fcr T\u00e4tigkeit im wissenschaftlichen Beirat von Biogen, Roche, Novo Nordisk, BioNTech, Lilly, Dr. Willmar Schwabe GmbH & Co. KG, RoX Health GmbH und MindAhead UG. | Nebent\u00e4tigkeit als Chef\u00e4rztin am Klinikum Hann. M\u00fcnden.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Direktorin der Klinik f\u00fcr Geriatrie, Universit\u00e4tsmedizin G\u00f6ttingen |S3-Leitlinienentwicklung: \u201eDemenz\u201c (Mitglied der Expertengruppe) und \u201eMenopause\u201c (Vertreterin der Deutschen Gesellschaft f\u00fcr Neurologie [DGN]); Deutsches Zentrum f\u00fcr Herz-Kreislauf-Forschung e.\u202fV. (DZHK) \u2013\u00a0seit 2023: Principal Investigator; Deutsche Gesellschaft f\u00fcr Neurologie (DGN) \u2013\u00a0seit 2023: Leiterin der Kommission Neurogeriatrie; Heart and Brain Center G\u00f6ttingen\u00a0\u2013 seit 2023: Vorstandsmitglied; \u00c4rzteverein G\u00f6ttingen \u2013\u00a0seit 2022: Vorsitzende; | Deutsches Netzwerk Ged\u00e4chtnisambulanzen (DNG) \u2013\u00a0seit 2021: Vorstandsmitglied, aktuell stellvertretender Vorstand; | Hirnliga e.\u202fV.\u00a0\u2013 seit 2021 Vorstandsmitglied; Forschungsvereinigung Feinmechanik, Optik und Medizintechnik e.\u202fV. (FOM)\u00a0\u2013 seit 2020: wissenschaftlicher Beirat; Medf3 \u2013\u00a0seit 2020; Alzheimer Stiftung G\u00f6ttingen\u00a0\u2013 seit 2019: Mitglied des Stiftungsbeirats; Herzzentrum G\u00f6ttingen \u2013\u00a0seit 2019; Deutsche Gesellschaft f\u00fcr Geriatrie (DGG) \u2013\u00a0seit 2017: Leiterin der Arbeitsgruppe Neurologie; Harvard European Alumni Training Network (HEAT-NET)\u00a0\u2013 seit 2005.","order":2,"name":"Ethics","label":"Autorinnen und Autoren","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":3,"name":"Ethics","label":"Wissenschaftliche Leitung","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","label":"Der Verlag","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}